{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:51:59Z","timestamp":1781531519693,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pompe disease is a rare autosomal recessive disease. Acid alpha\u2212glucosidase (GAA) deficiency leads to glycogen storage in lysosomes, causing skeletal, cardiac, and smooth muscle lesions. Pompe disease is progressive, and its severity depends on the age of onset. Classic infantile Pompe disease, the most severe form, is characterized by an age of onset before 12\u00a0months. Pompe disease with intrauterine onset has rarely been reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The proband was born at a gestational age of 40\u00a0weeks and 3\u00a0days and admitted to our hospital because of intrauterine cardiac hypertrophy, shortness of breath, and cyanosis until 13\u00a0min postnatally. Physical examination at admission revealed poor responsiveness, pale skin, shortness of breath, reduced limb muscle tone, and bilateral pedal edema. The heart sounds were weak, and no heart murmur was heard. Echocardiography showed left (9\u00a0mm) and right (5\u00a0mm) ventricular hypertrophies. The patient was subjected to non\u2212invasive ventilator\u2212assisted respiration, fluid restriction, diuresis, and metoprolol treatment. Infantile Pompe disease was diagnosed on day 16 with a GAA enzymatic activity of 0.31\u00a0\u00b5mol\/L\/h and with the full\u2212penetrance genetic test showing the homozygous gene mutation c.1844G&gt;T(p.Gly615Val). Enzyme replacement therapy was refused by the patient\u2019s parents, and the patient died at seven months of age from cardiopulmonary failure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Infants with intrauterine\u2212onset Pompe disease usually have early manifestations of heart disease. Prompt GAA enzymatic activity determination and molecular genetic testing are helpful in aiding the parents\u2019 decision and planning the treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-022-01379-3","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T05:02:40Z","timestamp":1669006960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Infantile Pompe disease with intrauterine onset: a case report and literature review"],"prefix":"10.1186","volume":"48","author":[{"given":"Hongmin","family":"Xi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"1379_CR1","doi-asserted-by":"publisher","unstructured":"Meena NK, Raben N. Pompe Disease: New Developments in an Old Lysosomal Storage Disorder.\u00a0Biomolecules. 2020;10(9):1339. Published 2020 Sep 18. doi:https:\/\/doi.org\/10.3390\/biom10091339","DOI":"10.3390\/biom10091339"},{"issue":"2","key":"1379_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1590\/0004-282X20150194","volume":"74","author":"JC Llerena Junior","year":"2016","unstructured":"Llerena Junior JC, Nascimento OJ, Oliveira AS, et al. Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease. Arq Neuropsiquiatr. 2016;74(2):166\u201376. https:\/\/doi.org\/10.1590\/0004-282X20150194.","journal-title":"Arq Neuropsiquiatr"},{"key":"1379_CR3","doi-asserted-by":"publisher","unstructured":"Hamdan MA, El-Zoabi BA, Begam MA, Mirghani HM, Almalik MH. Antenatal diagnosis of pompe disease by fetal echocardiography impact on outcome after early initiation of enzyme replacement therapy.\u00a0J Inherit Metab Dis. 2010,33 Suppl 3S333-S339.\u00a0https:\/\/doi.org\/10.1007\/s10545-010-9179-2.","DOI":"10.1007\/s10545-010-9179-2"},{"issue":"9","key":"1379_CR4","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1002\/ajmg.a.38333","volume":"173","author":"AC Tsai","year":"2017","unstructured":"Tsai AC, Hung YW, Harding C, Koeller DM, Wang J, Wong LC. Next generation deep sequencing corrects diagnostic pitfalls of traditional molecular approach in a patient with prenatal onset of Pompe disease. Am J Med Genet A. 2017;173(9):2500\u20134. https:\/\/doi.org\/10.1002\/ajmg.a.38333.","journal-title":"Am J Med Genet A"},{"key":"1379_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/8904_2011_85","volume":"5","author":"DT Swarr","year":"2012","unstructured":"Swarr DT, Kaufman B, Fogel MA, Finkel R, Ganesh J. Unusual cardiac \u201cmasses\u201c in a newborn with infantile pompe disease. JIMD Rep. 2012;5:17\u201320. https:\/\/doi.org\/10.1007\/8904_2011_85.","journal-title":"JIMD Rep"},{"key":"1379_CR6","doi-asserted-by":"publisher","unstructured":"Gupta P, Shayota BJ, Desai AK, et al. A Race Against Time-Changing the Natural History of CRIM Negative Infantile Pompe Disease.\u00a0Front Immunol. 2020;11:1929. Published 2020 Sep 4.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2020.01929.","DOI":"10.3389\/fimmu.2020.01929"},{"issue":"11","key":"1379_CR7","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/humu.23878","volume":"40","author":"AJJ Reuser","year":"2019","unstructured":"Reuser AJJ, van der Ploeg AT, Chien YH, et al. GAA variants and phenotypes among 1,079 patients with Pompe disease Data from the Pompe Registry. Hum Mutat. 2019;40(11):2146\u201364. https:\/\/doi.org\/10.1002\/humu.23878.","journal-title":"Hum Mutat"},{"issue":"9646","key":"1379_CR8","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","volume":"372","author":"AT Van der Ploeg","year":"2008","unstructured":"Van der Ploeg AT, Reuser AJ. Pompe\u2019s disease. Lancet. 2008;372(9646):1342\u201353. https:\/\/doi.org\/10.1016\/S0140-6736(08)61555-X.","journal-title":"Lancet"},{"key":"1379_CR9","doi-asserted-by":"publisher","unstructured":"Gu J, Geng M, Qi M, Wang L, Zhang Y, Gao J. The role of lysosomal membrane proteins in glucose and lipid metabolism. FASEB J.\u00a02021;35(10):e21848. https:\/\/doi.org\/10.1096\/fj.202002602R.","DOI":"10.1096\/fj.202002602R"},{"issue":"5","key":"1379_CR10","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41436-020-01070-0","volume":"23","author":"D Marsden","year":"2021","unstructured":"Marsden D, Bedrosian CL, Vockley J. Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders. Genet Med. 2021;23(5):816\u201329. https:\/\/doi.org\/10.1038\/s41436-020-01070-0.","journal-title":"Genet Med"},{"issue":"9","key":"1379_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/gim.2014.177","volume":"17","author":"S Parikh","year":"2015","unstructured":"Parikh S, Goldstein A, Koenig MK, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2015;17(9):689\u2013701. https:\/\/doi.org\/10.1038\/gim.2014.177.","journal-title":"Genet Med"},{"issue":"4","key":"1379_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.pedneo.2013.03.009","volume":"54","author":"YH Chien","year":"2013","unstructured":"Chien YH, Hwu WL, Lee NC. Pompe disease: early diagnosis and early treatment make a difference. Pediatr Neonatol. 2013;54(4):219\u201327. https:\/\/doi.org\/10.1016\/j.pedneo.2013.03.009.","journal-title":"Pediatr Neonatol"},{"issue":"23 Suppl 2","key":"1379_CR13","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1212\/WNL.0b013e31818da91e","volume":"71","author":"B Bembi","year":"2008","unstructured":"Bembi B, Cerini E, Danesino C, et al. Diagnosis of glycogenosis type II. Neurology. 2008;71(23 Suppl 2):S4\u201311. https:\/\/doi.org\/10.1212\/WNL.0b013e31818da91e.","journal-title":"Neurology"},{"issue":"1","key":"1379_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/01913120601169469","volume":"31","author":"DJ Fowler","year":"2007","unstructured":"Fowler DJ, Anderson G, Vellodi A, Malone M, Sebire NJ. Electron microscopy of chorionic villus samples for prenatal diagnosis of lysosomal storage disorders. Ultrastruct Pathol. 2007;31(1):15\u201321. https:\/\/doi.org\/10.1080\/01913120601169469.","journal-title":"Ultrastruct Pathol"},{"key":"1379_CR15","doi-asserted-by":"publisher","unstructured":"van der Ploeg AT, Kruijshaar ME, Toscano A, et al. European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience. Eur J Neurol.\u00a02017;24(6):768\u2013e31. https:\/\/doi.org\/10.1111\/ene.13285.","DOI":"10.1111\/ene.13285"},{"issue":"2","key":"1379_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.34763\/jmotherandchild.20202402si.2001.000002","volume":"24","author":"JE Davison","year":"2020","unstructured":"Davison JE. Advances in diagnosis and management of Pompe disease. J Mother Child. 2020;24(2):3\u20138. https:\/\/doi.org\/10.34763\/jmotherandchild.20202402si.2001.000002 (Published 2020 Oct 2).","journal-title":"J Mother Child"},{"key":"1379_CR17","doi-asserted-by":"publisher","unstructured":"Yang CF, Yang CC, Liao HC, et al. Very early treatment for infantile-onset Pompe disease contributes to better outcomes. J Pediatr.\u00a02016;169:174\u201380.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2015.10.078.","DOI":"10.1016\/j.jpeds.2015.10.078"},{"key":"1379_CR18","doi-asserted-by":"publisher","unstructured":"Chien YH, Chiang SC, Zhang XK, et al. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. Pediatrics.\u00a02008;122(1):e39\u201345. https:\/\/doi.org\/10.1542\/peds.2007-2222.","DOI":"10.1542\/peds.2007-2222"},{"issue":"6","key":"1379_CR19","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.3390\/ijms21062256","volume":"21","author":"AF Fusco","year":"2020","unstructured":"Fusco AF, McCall AL, Dhindsa JS, et al. The Respiratory Phenotype of Pompe Disease Mouse Models. Int J Mol Sci. 2020;21(6):2256. https:\/\/doi.org\/10.3390\/ijms21062256 (Published 2020 Mar 24).","journal-title":"Int J Mol Sci"},{"issue":"9646","key":"1379_CR20","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-XGaa","volume":"372","author":"AT van der Ploeg","year":"2008","unstructured":"van der Ploeg AT, Reuser AJ. Pompe\u2019s disease. Lancet. 2008;372(9646):1342\u201353. https:\/\/doi.org\/10.1016\/S0140-6736(08)61555-XGaa.","journal-title":"Lancet"},{"key":"1379_CR21","doi-asserted-by":"publisher","unstructured":"Keeler AM, Liu D, Zieger M, et al. Airway smooth muscle dysfunction in Pompe (Gaa-\/- ) mice. Am J Physiol Lung Cell Mol Physiol.\u00a02017;312(6):L873\u201381. https:\/\/doi.org\/10.1152\/ajplung.00568.2016.","DOI":"10.1152\/ajplung.00568.2016"},{"issue":"11","key":"1379_CR22","doi-asserted-by":"publisher","first-page":"CD011539","DOI":"10.1002\/14651858.CD011539.pub2","volume":"11","author":"M Chen","year":"2017","unstructured":"Chen M, Zhang L, Quan S. Enzyme replacement therapy for infantile-onset Pompe disease. Cochrane Database Syst Rev. 2017;11(11):CD011539. https:\/\/doi.org\/10.1002\/14651858.CD011539.pub2 (Published 2017 Nov 20).","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-022-01379-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-022-01379-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-022-01379-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T05:02:43Z","timestamp":1669006963000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-022-01379-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1379"],"URL":"https:\/\/doi.org\/10.1186\/s13052-022-01379-3","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,21]]},"assertion":[{"value":"27 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study approval and ethical clearance were obtained from the Affiliated.Hospital of Qingdao University. Written consent was obtained from the.guardian of the child before data collection.\u00a0All methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained the written consent for publication from the guardian of the.patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}